Primary Central Nervous System Lymphoma

Primary Central Nervous System Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

145 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 55
Recruiting: 38
Ph III recruiting: 5
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (10)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06646211	High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)	not yet recruiting	Phase 2	30	Sun Yat-sen UniversityOTHER	1	Oct 17, 2024	clinicaltrials
NCT05347641	Penpulimab Combined With RMA Treatment of Primary Diagnosis of Primary Central Nervous System Lymphoma	not yet recruiting	Phase 2	23	The First Affiliated Hospital with Nanjing Medical UniversityOTHER	0	Apr 26, 2022